2.60
Sarepta Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
2.56
FY23:
2.58
FY24:
3.07
FY25:
2.54
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.54
FY22:
0.57
FY23:
0.69
FY24:
0.89
FY25:
0.81
Total assets
Change from FY21 to FY25
billions USD
FY21:
3.15
FY22:
3.13
FY23:
3.26
FY24:
3.96
FY25:
3.35
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.62
FY23:
0.65
FY24:
0.73
FY25:
1.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.77
FY22:
2.12
FY23:
1.75
FY24:
1.70
FY25:
1.11
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.93
FY22:
0.38
FY23:
0.86
FY24:
1.53
FY25:
1.14
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
3.15
FY22:
3.13
FY23:
3.26
FY24:
3.96
FY25:
3.35
All amounts in billions USD